Transient elevation of neutrophil proteinases in induced sputum during COPD exacerbation

References

• Soler‐Cataluna J. J., Martinez‐Garcia M. A., Roman S. P., Salcedo E., Navarro M., Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925–31
   PubMed Web of Science ®Google Scholar
• Anthonisen N. R., Manfreda J., Warren C. P., Hershfield E. S., Harding G. K., Nelson N. A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196–204
   PubMed Web of Science ®Google Scholar
• Sapey E., Stockley R. A. COPD exacerbations. 2: Aetiology. Thorax 2006; 61: 250–8
   PubMed Web of Science ®Google Scholar
• Aaron S. D., Angel J. B., Lunau M., Wright K., Fex C., Le S. N., et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 349–55
   PubMed Web of Science ®Google Scholar
• Balbi B., Bason C., Balleari E., Fiasella F., Pesci A., Ghio R., et al. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony‐stimulating factor during exacerbations of chronic bronchitis. Eur Respir J 1997; 10: 846–50
   PubMed Web of Science ®Google Scholar
• Selby C., Drost E., Lannan S., Wraith P. K., MacNee W. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143: 1359–64
   PubMed Web of Science ®Google Scholar
• Tsoumakidou M., Tzanakis N., Chrysofakis G., Kyriakou D., Siafakas N. M. Changes in sputum T‐lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med 2005; 99: 572–9
   PubMedGoogle Scholar
• Fujimoto K., Yasuo M., Urushibata K., Hanaoka M., Koizumi T., Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005; 25: 640–6
   PubMed Web of Science ®Google Scholar
• Gompertz S., O'Brien C., Bayley D. L., Hill S. L., Stockley R. A. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001; 17: 1112–19
   PubMed Web of Science ®Google Scholar
• White A. J., Gompertz S., Bayley D. L., Hill S. L., O'Brien C., Unsal I., et al. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax 2003; 58: 680–5
   PubMed Web of Science ®Google Scholar
• Damiano V. V., Tsang A., Kucich U., Abrams W. R., Rosenbloom J., Kimbel P., et al. Immunolocalization of elastase in human emphysematous lungs. J Clin Invest 1986; 78: 482–93
   PubMed Web of Science ®Google Scholar
• Janoff A., Sloan B., Weinbaum G., Damiano V., Sandhaus R. A., Elias J., et al. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis 1977; 115: 461–78
   PubMed Web of Science ®Google Scholar
• Senior R. M., Tegner H., Kuhn C., Ohlsson K., Starcher B. C., Pierce J. A. The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis 1977; 116: 469–75
   PubMed Web of Science ®Google Scholar
• Shapiro S. D. Proteinases in COPD. Chronic obstructive pulmonary disease: Taylor & Francis Group, LCC, P. J Barnes, 2005; 327–65
   Google Scholar
• Segura‐Valdez L., Pardo A., Gaxiola M., Uhal B. D., Becerril C., Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117: 684–94
   PubMed Web of Science ®Google Scholar
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: S77–121
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease NHLBI/WHO Workshop Report. NIH Publication No. 2701. 2002. Available at: www.gold.copd.com (accessed December 2006).
   Google Scholar
• Rytila P., Rehn T., Ilumets H., Rouhos A., Sovijarvi A., Myllarniemi M., et al. Increased oxidative stress in asymptomatic current chronic smokers and GOLD Stage 0 COPD. Respir Res 2006; 7: 69
   PubMed Web of Science ®Google Scholar
• Djukanovic R., Sterk P. J., Fahy J. V., Hargreave F. E. Standardised methodology of sputum induction and processing. Eur Respir J Suppl 2002; 37: 1s–2s
   PubMedGoogle Scholar
• Bieth J., Spiess B., Wermuth C. G. The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem Med 1974; 11: 350–7
   PubMed Web of Science ®Google Scholar
• Ingman T., Sorsa T., Konttinen Y. T., Liede K., Saari H., Lindy O., et al. Salivary collagenase, elastase‐ and trypsin‐like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis. Oral Microbiol Immunol 1993; 8: 298–305
   PubMedGoogle Scholar
• Holopainen J. M., Moilanen J. A., Sorsa T., Kivela‐Rajamaki M., Tervahartiala T., Vesaluoma M. H., et al. Activation of matrix metalloproteinase‐8 by membrane type 1‐MMP and their expression in human tears after photorefractive keratectomy. Invest Ophthalmol Vis Sci 2003; 44: 2550–6
   PubMed Web of Science ®Google Scholar
• Donaldson G. C., Seemungal T. A., Bhowmik A., Wedzicha J. A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847–52
   PubMed Web of Science ®Google Scholar
• Barnes P. J. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56: 515–48
   PubMed Web of Science ®Google Scholar
• Saetta M., Turato G., Maestrelli P., Mapp C. E., Fabbri L. M. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1304–9
   PubMed Web of Science ®Google Scholar
• Beeh K. M., Beier J., Kornmann O., Buhl R. Sputum matrix metalloproteinase‐9, tissue inhibitor of metalloprotinease‐1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med 2003; 97: 634–9
   PubMed Web of Science ®Google Scholar
• Russell R. E., Culpitt S. V., DeMatos C., Donnelly L., Smith M., Wiggins J., et al. Release and activity of matrix metalloproteinase‐9 and tissue inhibitor of metalloproteinase‐1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 26: 602–9
   PubMed Web of Science ®Google Scholar
• Mercer P. F., Shute J. K., Bhowmik A., Donaldson G. C., Wedzicha J. A., Warner J. A. MMP‐9, TIMP‐1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 2005; 6: 151
   PubMed Web of Science ®Google Scholar
• Golub L. M., Lee H. M., Ryan M. E., Giannobile W. V., Payne J., Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non‐antimicrobial mechanisms. Adv Dent Res 1998; 12: 12–26
   PubMedGoogle Scholar